In fact, as Teeguarden et al. note, they are not the first to call out vom Saal for unscientific tactics in academic research.

FORBES: Top Government Scientists Catch Media's Favorite Anti BPA Researcher in Absurd Claims, Ties To Trial Lawyers

More important, research-based drug firms are using a variety of tactics to make the patent cliff slope more gently.

ECONOMIST: Drugmakers